Cancer affects millions worldwide, leading to deaths and treatment-related adverse health effects while significantly burdening the economy. Conventional therapies may seem adequate for a while but eventually fail patients. This treatment failure is primarily due to increased drug resistance.

The genetic basis for cancer means that it can be targeted with genome editing technologies, such as CRISPR. This explains why CRISPR genome engineering is creating a revolution in cancer therapy.

Read our eBook to stay updated on the latest trends in the field.

This eBook covers CRISPR-based innovations to overcome cancer therapy resistance and immuno-oncology breakthroughs.

You will learn about the following topics:

  • Conventional approaches to cancer therapy and mechanisms of drug resistance
  • Overcoming drug resistance and novel drug target identification with CRISPR screening
  • CRISPR gene editing in advancing immuno-oncology
  • Future directions with genome engineering technologies